Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II tria...

by Orlando, Laura, Lorusso, Vito, Giotta, Francesco, Di Maio, Massimo, Schiavone, Paola, Fedele, Palma, Quaranta, Annamaria, Caliolo, Chiara, Ciccarese, Mariangela, Cinefra, Margherita, Romito, Sante, Pisconti, Salvatore, Prete, Salvatore del, Aieta, Michele, Rizzi, Daniele, Maiello, Evaristo, Colucci, Giuseppe, Cinieri, Saverio
Published in Breast (2020)

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience

by Lutrino, Eufemia S., Orlando, Laura, Febbraro, Antonio, Giampaglia, Marianna, Zamagni, Claudio, Schiavone, Paola, Scavelli, Claudio, Dima, Gianluca, Fedele, Palma, Giordano, Guido, Bilancia, Domenico, Quaranta, Anna Maria, Rubino, Daniela, Filippelli, Gianfranco, Fontanella, Caterina, Caliolo, Chiara, Marino, Antonella, Calvani, Nicola, Ferrara, Pasqualinda, Cinieri, Saverio
Published in Tumori (2019)

INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial—the INCA study protocol

by Goss, Claudia, Ghilardi, Alberto, Deledda, Giuseppe, Buizza, Chiara, Bottacini, Alessandro, Del Piccolo, Lidia, Rimondini, Michela, Chiodera, Federica, Mazzi, Maria Angela, Ballarin, Mario, Bighelli, Irene, Strepparava, Maria Grazia, Molino, Annamaria, Fiorio, Elena, Nortilli, Rolando, Caliolo, Chiara, Zuliani, Serena, Auriemma, Alessandra, Maspero, Federica, Simoncini, Edda Lucia, Ragni, Fulvio, Brown, Richard, Zimmermann, Christa
Published 2013